MACROGENICS, INC. Earnings Per Share (Basic)
MACROGENICS, INC. (MGNX) reported Earnings Per Share (Basic) of $0.31 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- MACROGENICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was $0.31.
- MACROGENICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.58.
- MACROGENICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was $0.27, a 70.00% decline year-over-year.
- MACROGENICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.57.
- MACROGENICS, INC. earnings per share, basic for fiscal 2025 was -$1.18.
- MACROGENICS, INC. earnings per share, basic for fiscal 2024 was -$1.07.
- MACROGENICS, INC. earnings per share, basic for fiscal 2023 was -$0.15.
- MACROGENICS, INC. earnings per share, basic for fiscal 2022 was -$1.95.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.31 10-Q · filed 2026-08-14 | -$0.27 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | -$0.58 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | -$1.18 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $0.27 10-Q · filed 2025-11-12 | -$0.96 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$0.57 10-Q · filed 2026-08-14 | -$1.23 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | -$0.65 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$1.07 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $0.90 10-Q · filed 2025-11-12 | -$0.82 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$0.89 10-Q · filed 2025-08-14 | -$1.73 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$0.84 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | -$0.15 10-K · filed 2026-03-09 | |||
| 2023-09-30 | $0.28 10-Q · filed 2024-11-05 | $0.60 10-Q · filed 2024-11-05 | ||
| 2023-06-30 | $0.93 10-Q · filed 2024-08-06 | $0.31 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | -$0.61 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.95 10-K · filed 2025-03-20 | |||
| 2022-09-30 | -$0.40 10-Q · filed 2023-11-06 | -$2.16 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | -$0.67 10-Q · filed 2023-08-09 | -$1.76 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$1.08 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$3.37 10-K · filed 2024-03-07 | |||
| 2021-09-30 | -$0.86 10-Q · filed 2022-11-03 | -$2.42 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$0.66 10-Q · filed 2022-08-08 | -$1.56 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$0.90 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | -$2.47 10-K · filed 2023-03-15 | |||
| 2020-09-30 | -$0.66 10-Q · filed 2021-11-02 | -$2.49 10-Q · filed 2021-11-02 | ||
| 2020-06-30 | -$0.94 10-Q · filed 2021-07-29 | -$1.85 10-Q · filed 2021-07-29 | ||
| 2017-12-31 | $2.87 10-K · filed 2019-02-26 | |||
| 2017-09-30 | -$1.28 10-K · filed 2019-02-26 | |||
| 2017-06-30 | -$1.14 10-K · filed 2019-02-26 | -$2.21 10-Q · filed 2017-08-02 | ||
| 2017-03-31 | -$1.08 10-K · filed 2019-02-26 | |||
| 2016-12-31 | -$1.00 10-K · filed 2018-02-27 | |||
| 2016-09-30 | -$0.97 10-K · filed 2018-02-27 | -$0.69 10-Q · filed 2016-11-02 | ||
| 2016-06-30 | $1.17 10-K · filed 2018-02-27 | $0.29 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | -$0.88 10-K · filed 2018-02-27 | |||
| 2015-12-31 | -$0.83 10-K · filed 2017-02-28 | |||
| 2015-09-30 | -$0.46 10-K · filed 2017-02-28 | $0.27 10-Q · filed 2016-11-02 | ||
| 2015-06-30 | -$0.71 10-K · filed 2017-02-28 | $0.80 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | $1.53 10-K · filed 2017-02-28 | |||
| 2014-12-31 | -$0.68 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.83 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$1.27 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$1.40 10-K · filed 2015-03-03 |
| 2014-09-30 | -$0.14 10-Q · filed 2015-11-04 | -$0.58 derived: net income ÷ weighted average shares · filed 2015-11-04 | -$0.71 10-Q · filed 2015-11-04 | |
| 2014-06-30 | -$0.44 10-Q · filed 2015-08-05 | -$0.57 10-Q · filed 2015-08-05 | ||
| 2014-03-31 | -$0.12 10-Q · filed 2015-05-06 | |||
| 2013-12-31 | -$0.14 10-K · filed 2015-03-03 | -$0.04 10-K · filed 2015-03-03 | ||
| 2013-09-30 | $0.14 10-K · filed 2015-03-03 | -$0.10 derived: net income ÷ weighted average shares · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | |
| 2013-06-30 | -$0.24 10-K · filed 2015-03-03 | -$3.00 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | -$2.93 10-K · filed 2015-03-03 | |||
| 2012-12-31 | -$1.92 10-K · filed 2014-03-20 | $0.00 10-K · filed 2015-03-03 | ||
| 2012-09-30 | $0.00 10-K · filed 2014-03-20 | $0.00 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $0.00 10-K · filed 2014-03-20 | |||
| 2012-03-31 | $0.00 10-K · filed 2014-03-20 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |